ArticleAnnals of surgical oncology2022

Clinical, Pathological Complete Response, and Prognosis Characteristics of HER2-Low Breast Cancer in the Neoadjuvant Chemotherapy Setting: A Retrospective Analysis.

Yingbo Shao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.